Avalo Therapeutics (AVTX) R&D In Process (2018 - 2024)
Historic R&D In Process for Avalo Therapeutics (AVTX) over the last 3 years, with Q2 2024 value amounting to $103000.0.
- Avalo Therapeutics' R&D In Process changed N/A to $103000.0 in Q2 2024 from the same period last year, while for Mar 2025 it was $103000.0, marking a year-over-year decrease of 9962.6%. This contributed to the annual value of $27.6 million for FY2024, which is N/A changed from last year.
- According to the latest figures from Q2 2024, Avalo Therapeutics' R&D In Process is $103000.0.
- In the past 5 years, Avalo Therapeutics' R&D In Process ranged from a high of $27.5 million in Q1 2024 and a low of $103000.0 during Q2 2024